Letter: Rifaximin Versus Low FODMAP Diet in IBS : What the Primary Endpoint Does Not Tell Us. Authors' Reply

Alimentary Pharmacology & Therapeutics 2026 Open access

Read full text
Authors: Kee Huat Chuah, Qing Yuan Loo, Audrey Joe Chii Loh, Jing Yi Leong, Wah Loong Chan, Xin Hui Khoo, Wong Kt, Sarala Panirsheeluam, Vicraman Natarajan, Ai Kah Ng, Hazreen Abdul Majid, Sanjiv Mahadeva
DOI: 10.1111/apt.70553
Cited by: 0
References: 9

Fields of Study & Subjects

Gastrointestinal motility and disorders Gut microbiota and health Inflammatory Bowel Disease

Publication details

Journal / source
Alimentary Pharmacology & Therapeutics
Volume
63
Issue
6
Pages
909–910
Publication date
29 January 2026
Language
EN